Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 2/20 | 0.48 |
| ▸ | TAS1R3 | Q7RTX0 | 2/20 | 0.35 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
| ▸ | TAS1R2 | Q8TE23 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 3/20 | 0.33 |
| ▸ | RAB9A | P51151 | 2/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.32 |
| ▸ | CTSL | P07711 | 1/20 | 0.32 |
| ▸ | ACE | P12821 | 1/20 | 0.32 |
| ▸ | CTSB | P07858 | 1/20 | 0.32 |
| ▸ | CTSS | P25774 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Stepronin SCHEMBL19338 | 0.83 | ELANE (0.56) | ELANEHPGDTSHRNPC1RAB9A | |
| Stepronin SCHEMBL19339 | 0.83 | ELANE (0.56) | ELANEHPGDTSHRNPC1RAB9A | |
| Stepronin SCHEMBL1651441 | 0.72 | ELANE (0.54) | ELANEHPGDTSHRNPC1RAB9A | |
| SCHEMBL11176247 | 0.68 | ELANE (0.47) | ELANEHPGDTSHRL3MBTL1KMT2A | |
| SCHEMBL11189010 | 0.66 | ELANE (0.59) | ELANEHPGDNPC1RAB9AKMT2A | |
| SCHEMBL11189007 | 0.66 | ELANE (0.59) | ELANEHPGDNPC1RAB9AKMT2A | |
| SCHEMBL7314482 | 0.66 | ELANE (0.56) | ELANEHPGDNPC1RAB9AKMT2A | |
| SCHEMBL10589127 | 0.65 | ELANE (0.53) | ELANEHPGDTSHRNPC1RAB9A | |
| Midesteine SCHEMBL724755 | 0.65 | ELANE (1.00) | ELANEHPGDKMT2AMEN1ALDH1A1 | |
| SCHEMBL10505335 | 0.65 | MME (0.48) | HPGDKMT2AMEN1ACEALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040071777-A1 | Solid dispersions of nitrate active principles | NICOX S.A. (FR) | 2004-04-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040071777-A1 | Solid dispersions of nitrate active principles | PGD, NOS3, SORD | ELANE 1038/4885TAS1R3 1694/4885HPGD 24/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.